The Clorox Company (CLX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Oct, 2026Executive summary
Annual meeting scheduled for Nov. 18, 2026, at 9:00 a.m. PST, virtually.
Voting matters and shareholder proposals
Shareholders will vote on director elections, advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor.
The Board recommends FOR all three matters.
Board of directors and corporate governance
Ten director nominees: Gina Boswell, Stephen B. Bratspies, Pierre R. Breber, Julia Denman, Esther Lee, Stephanie Plaines, Linda Rendle, Matthew J. Shattock, Russell J. Weiner, and Christopher J. Williams.
Partial view of Summaries dataset, powered by Quartr API
Latest events from The Clorox Company
- CEO succession, transformation milestones and below-target incentives define FY26.CLX
Proxy filing - Innovation and health & hygiene drive growth amid leadership transition and inflationary pressures.CLX
Boston Global Staples Conference 2026 - FY27 outlook: double-digit sales growth, higher EPS, and GOJO and ERP integration benefits.CLX
Q4 2026 - ERP stabilization, innovation, and GOJO integration drive growth amid leadership transition.CLX
23rd annual dbAccess Global Consumer Conference - Q2 FY2026 sales and earnings declined, with major acquisitions and ongoing cost pressures.CLX
Q2 2026 - $2.25B acquisition expands health & hygiene leadership, driving $50M in synergies.CLX
M&A announcement - Net sales fell 19% and gross margin dropped to 41.7% amid ERP transition impacts.CLX
Q1 2026 - FY25 margin and EPS growth driven by ERP shipments, with FY26 headwinds as benefits reverse.CLX
Q4 2025 - Digital transformation and IGNITE strategy accelerate growth, margin expansion, and innovation.CLX
Consumer Analyst Group of New York Conference 2025